BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37085428)

  • 1. Comparative analysis of the vaginal microbiome of healthy and polycystic ovary syndrome women: a large cross-sectional study.
    Jin C; Qin L; Liu Z; Li X; Gao X; Cao Y; Zhao S; Wang J; Han T; Yan L; Song J; Zhang F; Liu F; Zhang Y; Huang Y; Song Y; Liu Y; Yao Z; Chen H; Zhang Z; Zhao S; Feng Y; Zhang YN; Qian Y; Sun T; Feng Q; Zhao H
    Reprod Biomed Online; 2023 Jun; 46(6):1005-1016. PubMed ID: 37085428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Vaginal Microbiome Diversity in Women With Polycystic Ovary Syndrome.
    Lu C; Wang H; Yang J; Zhang X; Chen Y; Feng R; Qian Y
    Front Cell Infect Microbiol; 2021; 11():755741. PubMed ID: 34804995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between polycystic ovary syndrome and the vaginal microbiome: A case-control study.
    Hong X; Qin P; Huang K; Ding X; Ma J; Xuan Y; Zhu X; Peng D; Wang B
    Clin Endocrinol (Oxf); 2020 Jul; 93(1):52-60. PubMed ID: 32311120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Manifestations of Polycystic Ovary Syndrome and Associations With the Vaginal Microbiome: A Cross-Sectional Based Exploratory Study.
    Hong X; Qin P; Yin J; Shi Y; Xuan Y; Chen Z; Zhou X; Yu H; Peng D; Wang B
    Front Endocrinol (Lausanne); 2021; 12():662725. PubMed ID: 33967963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling intestinal microbiota's dominance in polycystic ovary syndrome pathogenesis over vaginal microbiota.
    Yu X; Li X; Yang H
    Front Cell Infect Microbiol; 2024; 14():1364097. PubMed ID: 38606298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of the vaginal microbiome with oral contraceptive therapy in women with polycystic ovary syndrome: a 6-month longitudinal cohort study.
    Hong X; Qin P; Gao L; Huang L; Shi Y; Peng D; Wang B
    BMC Med; 2023 Dec; 21(1):478. PubMed ID: 38041079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.
    Wongwananuruk T; Panichyawat N; Indhavivadhana S; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Pratumvinit B; Sa-Nga-Areekul N
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):499-506. PubMed ID: 30122568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
    Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between obesity and weight loss after bariatric surgery on the vaginal microbiota.
    Raglan O; MacIntyre DA; Mitra A; Lee YS; Smith A; Assi N; Nautiyal J; Purkayastha S; Gunter MJ; Gabra H; Marchesi JR; Bennett PR; Kyrgiou M
    Microbiome; 2021 May; 9(1):124. PubMed ID: 34049596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
    Dilaver N; Pellatt L; Jameson E; Ogunjimi M; Bano G; Homburg R; D Mason H; Rice S
    Hum Reprod; 2019 Dec; 34(12):2467-2479. PubMed ID: 31735954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal Dysbiotic Microbiome in Women With No Symptoms of Genital Infections.
    Pramanick R; Nathani N; Warke H; Mayadeo N; Aranha C
    Front Cell Infect Microbiol; 2021; 11():760459. PubMed ID: 35096634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome.
    Wong HYQ; Li HWR; Lam KSL; Tam S; Shek CC; Lee CYV; Yeung WSB; Ho PC; Ng EHY
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):634-641. PubMed ID: 30019416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
    Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
    Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome.
    Dong S; Jiao J; Jia S; Li G; Zhang W; Yang K; Wang Z; Liu C; Li D; Wang X
    Front Cell Infect Microbiol; 2021; 11():634981. PubMed ID: 34041041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.